As Chief Scientific Officer at Tricol Biomedical, my mission intertwines with the pioneering of groundbreaking biocompatible hemostatic materials that drive medical advancements. With over a decade at the forefront of technology innovation, my role encompasses leading science communication, fostering technology partnerships, and adeptly managing resources to catalyze scientific progress. My expertise in hemostasis, polysaccharides and chemistry has been instrumental in the development of novel wound treatments and hemostatic products. At Tricol, our team has harnessed the power of collaboration to translate scientific knowledge into tangible solutions, enriching lives and carving new frontiers in the field of biomaterials.